Phase 1 safety, efficacy, and pharmacokinetic study of Paclitaxel nano-dispersion injection in subjects with metastatic breast cancer: A randomized, open label, dose-ranging, active controlled, comparative, parallel group, and multi-centric study.
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Sun Pharma Advanced Research Company
- 15 Jan 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 02 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 01 Jul 2009 New trial record